{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:54:08Z","timestamp":1790189648223,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1124\/jpet.109.161885","type":"journal-article","created":{"date-parts":[[2009,11,26]],"date-time":"2009-11-26T05:08:08Z","timestamp":1259212088000},"page":"1040-1053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Limiting Activity at \u03b21-Subunit-Containing GABAA Receptor Subtypes Reduces Ataxia"],"prefix":"10.1016","volume":"332","author":[{"given":"Kelvin W.","family":"Gee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhtam B.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derk J.","family":"Hogenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy E.","family":"Bagnera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan F.","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Belluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Whittemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.109.161885_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF00227337","article-title":"GABAergic and pallidal terminals in the thalamic reticular nucleus of squirrel monkeys","volume":"101","author":"Asanuma","year":"1994","journal-title":"Exp Brain Res"},{"key":"10.1124\/jpet.109.161885_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/jo00264a048","article-title":"Synthesis of 1-alkyl-1,2,4-triazoles: a new one-pot regiospecific procedure","volume":"54","author":"Astleford","year":"1989","journal-title":"J Org Chem"},{"key":"10.1124\/jpet.109.161885_bib3","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/jm00132a011","article-title":"Synthesis and structure-activity relationships of a series of anxioselective pyrazolopyridine ester and amide anxiolytic agents","volume":"32","author":"Bare","year":"1989","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.109.161885_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejphar.2004.07.043","article-title":"Anxioselective anxiolytics: can less be more?","volume":"500","author":"Basile","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.109.161885_bib5","first-page":"72","article-title":"Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models","volume":"17","author":"Bourin","year":"1992","journal-title":"J Psychiatry Neurosci"},{"key":"10.1124\/jpet.109.161885_bib6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1037\/0735-7044.112.3.668","article-title":"Genetic determinants of sensitivity to diazepam in inbred mice","volume":"112","author":"Crabbe","year":"1998","journal-title":"Behav Neurosci"},{"key":"10.1124\/jpet.109.161885_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9343(98)00091-6","article-title":"Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs","volume":"104","author":"Cryer","year":"1998","journal-title":"Am J Med"},{"key":"10.1124\/jpet.109.161885_bib8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0006-2952(88)90139-6","article-title":"Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptors","volume":"37","author":"Daly","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.109.161885_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0269881108092595","article-title":"The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers","volume":"23","author":"de Haas","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.109.161885_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0269881107082108","article-title":"Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers","volume":"22","author":"de Haas","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.109.161885_bib11","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1111\/j.1528-1157.1995.tb05993.x","article-title":"Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs","volume":"36","author":"Fisher","year":"1995","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.109.161885_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1460-9568.2006.04890.x","article-title":"The role of GABAbeta2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole","volume":"24","author":"Groves","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.109.161885_bib13","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1046\/j.1460-9568.1999.00709.x","article-title":"Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid","volume":"11","author":"Halliwell","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.109.161885_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0028-3908(03)00187-4","article-title":"The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunit","volume":"45","author":"Hamon","year":"2003","journal-title":"Neuropharmacology"},{"issue":"Suppl 5","key":"10.1124\/jpet.109.161885_bib15","first-page":"6","article-title":"Mechanisms of sleep induction by GABA(A) receptor agonists","volume":"68","author":"Harrison","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.109.161885_bib16","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1152\/jn.2000.83.5.2791","article-title":"High responsiveness and direction sensitivity of neurons in the rat thalamic reticular nucleus to vibrissa deflections","volume":"83","author":"Hartings","year":"2000","journal-title":"J Neurophysiol"},{"key":"10.1124\/jpet.109.161885_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0006-8993(91)90418-U","article-title":"Projection from the external pallidum to the reticular thalamic nucleus in the squirrel monkey","volume":"550","author":"Hazrati","year":"1991","journal-title":"Brain Res"},{"key":"10.1124\/jpet.109.161885_bib18","unstructured":"Heeres J (1985) inventor; Janssen Pharmaceutica N.V., assignee. 1-(2-Aryl-2-halo-1-ethenyl)-1 H-azoles, and anticonvulsant use thereof. U.S. patent 4,539,325. 1985 9 3."},{"key":"10.1124\/jpet.109.161885_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.bjp.0700927","article-title":"Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor","volume":"120","author":"Hill-Venning","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.109.161885_bib20","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1021\/jm070083v","article-title":"Enaminone amides as novel orally active GABAA receptor modulators","volume":"50","author":"Hogenkamp","year":"2007","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.109.161885_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1113\/jphysiol.2006.106617","article-title":"Fast IPSCs in rat thalamic reticular nucleus require the GABAA receptor beta1 subunit","volume":"572","author":"Huntsman","year":"2006","journal-title":"J Physiol"},{"key":"10.1124\/jpet.109.161885_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.161885_bib23","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1073\/pnas.0502579102","article-title":"Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator","volume":"102","author":"Lippa","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.109.161885_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.neuro.20.1.185","article-title":"Sleep and arousal: thalamocortical mechanisms","volume":"20","author":"McCormick","year":"1997","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/jpet.109.161885_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.109.161885_bib26","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1073\/pnas.0701321104","article-title":"Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators","volume":"104","author":"Ng","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.109.161885_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.757","article-title":"Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice","volume":"21","author":"Nguyen","year":"2006","journal-title":"Hum Psychopharmacol"},{"key":"10.1124\/jpet.109.161885_bib28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-8993(90)91832-2","article-title":"Substantia nigra pars reticulata projects to the reticular thalamic nucleus of the cat: a morphological and electrophysiological study","volume":"535","author":"Par\u00e9","year":"1990","journal-title":"Brain Res"},{"key":"10.1124\/jpet.109.161885_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.109.161885_bib30","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1124\/jpet.106.107201","article-title":"The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors","volume":"319","author":"Popik","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"#cr-split#-10.1124\/jpet.109.161885_bib31.1","unstructured":"Putman DG, Hogenkamp DJ, Dasse OA, Whittemore ER, Jensen MS (2007) inventors"},{"key":"#cr-split#-10.1124\/jpet.109.161885_bib31.2","unstructured":"Xytis Inc., assignee. Enantiomerically pure R-etifoxine, pharmaceutical compositions thereof and methods of their use. World patent, WO109288. 2007 9 27."},{"key":"10.1124\/jpet.109.161885_bib32","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1124\/jpet.109.161885_bib33","unstructured":"Skolnick P, Epstein JW (2005) inventors. 2-Pyridinyl[7-(substituted-pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones. U.S. patent application 20050245517. 2005 11 3."},{"key":"10.1124\/jpet.109.161885_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/jpet.104.070342","article-title":"Compounds exhibiting selective efficacy for different beta subunits of human recombinant gamma-aminobutyric acid A receptors","volume":"311","author":"Smith","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.109.161885_bib35","unstructured":"Sprenger KJ, Aneiro L, Fund L, Liu Y, Changchit A, Rajachandran L, Kehne JH, Xie L (2007) Clinical trial data demonstrating sedative-hypnotic efficacy of the \u03b13-subunit preferring GABAA receptor partial allosteric activator, NG2-73: translational validity of pharmacokinetic\/pharmacodynamic (PK\/PD) relationships derived from preclinical studies, in Proceedings of the Society for Neuroscience, 2007 Oct\u2013Nov 7; San Diego, CA. Program no. 632.2\/AAA17. Society for Neuroscience, Washington, DC."},{"key":"10.1124\/jpet.109.161885_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.brainres.2004.09.056","article-title":"Distribution of alpha1, alpha4, gamma2, and delta subunits of GABAA receptors in hippocampal granule cells","volume":"1029","author":"Sun","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/jpet.109.161885_bib37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0026-895X(24)12337-1","article-title":"Tracazolate reveals a novel type of allosteric interaction with recombinant gamma-aminobutyric acid(A) receptors","volume":"61","author":"Thompson","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.109.161885_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0173(02)00181-9","article-title":"The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness","volume":"39","author":"Van der Werf","year":"2002","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1124\/jpet.109.161885_bib39","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1523\/JNEUROSCI.4111-08.2009","article-title":"Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal","volume":"29","author":"Van Dort","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.109.161885_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coph.2005.08.005","article-title":"GABA-A receptors: a viable target for novel anxiolytics?","volume":"6","author":"Whiting","year":"2006","journal-title":"Curr Opin Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524456887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524456887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.109.161885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:06:47Z","timestamp":1740017207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524456887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0022356524456887"],"URL":"https:\/\/doi.org\/10.1124\/jpet.109.161885","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limiting Activity at \u03b21-Subunit-Containing GABAA Receptor Subtypes Reduces Ataxia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.109.161885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}